{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:51:41Z","timestamp":1787237501459,"version":"build-2736575974"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetic-associated chronic kidney disease (T2DM-Associated CKD), a leading cause of end-stage renal disease, is exacerbated by rising particularly high body mass index (BMI) rates. This study examines the global burden of T2DM-Associated CKD attributable to high BMI from 1990 to 2021 and projects future trends using the Global Burden of Disease (GBD) 2021 data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>GBD 2021 data from 204 countries were analyzed to assess mortality, disability-adjusted life years (DALYs) and corresponding age-standardized rates of T2DM-Associated CKD linked to high BMI. Bayesian Age-Period-Cohort modeling was used for projections, with stratification by age, gender, and Socio-Demographic Index (SDI). Statistical analyses were conducted using R software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2021, high BMI-related T2DM-Associated CKD caused 173,263 deaths and 4.3 million DALYs. Age-standardized rates declined globally but showed regional disparities, with Andean Latin America having the highest burden. Women had higher absolute burdens, while men showed higher standardized rates. Projections indicate continued increases in mortality and DALY rates through 2050. Emerging therapies, such as GLP-1 receptor agonists (RAs) and SGLT2 inhibitors (SGLT2i), could potentially alter these trends, especially in high-risk regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High BMI significantly drives the T2DM-Associated CKD burden, necessitating targeted overweight\/obesity prevention and improved healthcare access, particularly in high-risk regions. Monitoring trends is crucial for effective interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0333672","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:30:56Z","timestamp":1760117456000},"page":"e0333672","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trends and projections of the global burden of T2DM-associated CKD related to high BMI: A global burden of disease study 2021"],"prefix":"10.1371","volume":"20","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4653-8899","authenticated-orcid":true,"given":"Yangang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"18","key":"pone.0333672.ref001","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.3390\/ijms251810222","article-title":"Novel Insights into Diabetic Kidney Disease","volume":"25","author":"E M\u0142ynarska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"pone.0333672.ref002","doi-asserted-by":"crossref","first-page":"1285509","DOI":"10.3389\/fendo.2023.1285509","article-title":"Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study","volume":"14","author":"X Li","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"pone.0333672.ref003","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s42255-024-00977-1","article-title":"Determinants of obesity in Latin America","volume":"6","author":"SRG Ferreira","year":"2024","journal-title":"Nat Metab"},{"issue":"7","key":"pone.0333672.ref004","doi-asserted-by":"crossref","first-page":"740","DOI":"10.18553\/jmcp.2022.28.7.740","article-title":"Cost-effectiveness analysis of semaglutide 2.4\u2009mg for the treatment of adult patients with overweight and obesity in the United States","volume":"28","author":"N Kim","year":"2022","journal-title":"JMCP"},{"issue":"6","key":"pone.0333672.ref005","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1210\/clinem\/dgac057","article-title":"Body Mass Index and Risk of Diabetic Nephropathy: A Mendelian Randomization Study","volume":"107","author":"J Lu","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"pone.0333672.ref006","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41387-017-0012-y","article-title":"Associations between body mass index and the risk of renal events in patients with type 2 diabetes","volume":"8","author":"K Mohammedi","year":"2018","journal-title":"Nutr Diabetes"},{"issue":"4","key":"pone.0333672.ref007","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/dc19-1897","article-title":"Establishment and Validation of a Risk Prediction Model for Early Diabetic Kidney Disease Based on a Systematic Review and Meta-Analysis of 20 Cohorts","volume":"43","author":"W Jiang","year":"2020","journal-title":"Diabetes Care"},{"key":"pone.0333672.ref008","doi-asserted-by":"crossref","first-page":"1611227","DOI":"10.3389\/fnut.2025.1611227","article-title":"Global burden and trends of high BMI-attributable chronic kidney disease: a comprehensive analysis from 1990 to 2021 and projections to 2035","volume":"12","author":"H Tan","year":"2025","journal-title":"Front Nutr"},{"issue":"1","key":"pone.0333672.ref009","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","article-title":"Global trends and forecasts of breast cancer incidence and deaths","volume":"10","author":"Y Xu","year":"2023","journal-title":"Sci Data"},{"issue":"10258","key":"pone.0333672.ref010","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","journal-title":"Lancet"},{"key":"pone.0333672.ref011","doi-asserted-by":"crossref","first-page":"966093","DOI":"10.3389\/fpubh.2022.966093","article-title":"The global burden of type 2 diabetes attributable to high body mass index in 204 countries and territories, 1990-2019: An analysis of the Global Burden of Disease Study","volume":"10","author":"X Zhang","year":"2022","journal-title":"Front Public Health"},{"issue":"4","key":"pone.0333672.ref012","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4103\/ijc.IJC_1043_19","article-title":"Global pattern and trend of cervical cancer incidence from 1993 to 2012: Joinpoint regression and age-period-cohort analysis","volume":"59","author":"Y Krishnamoorthy","year":"2022","journal-title":"Indian J Cancer"},{"issue":"1","key":"pone.0333672.ref013","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12957-024-03582-4","article-title":"Impact of high body mass index on gallbladder and biliary tract cancer burden in China: a comprehensive analysis of trends from 1990 to 2021","volume":"22","author":"Z Zhan","year":"2024","journal-title":"World J Surg Oncol"},{"issue":"11","key":"pone.0333672.ref014","doi-asserted-by":"crossref","first-page":"100402","DOI":"10.1016\/j.jnha.2024.100402","article-title":"Spatiotemporal trends of Type 2 diabetes due to low physical activity from 1990 to 2019 and forecasted prevalence in 2050: A Global Burden of Disease Study 2019","volume":"28","author":"S Fan","year":"2024","journal-title":"J Nutr Health Aging"},{"key":"pone.0333672.ref015","doi-asserted-by":"crossref","DOI":"10.1186\/s12963-020-00219-y","article-title":"The burden of non-communicable diseases attributable to high BMI in Brazil, 1990\u20132017: findings from the Global Burden of Disease Study","volume":"18","author":"MS Felisbino-Mendes","year":"2020","journal-title":"Popul Health Metrics"},{"key":"pone.0333672.ref016","article-title":"Obesity prevalence in Mexico: impact on health and economic burden","author":"K Rtveladze","year":"2023","journal-title":"Public Health Nutrition"},{"issue":"1","key":"pone.0333672.ref017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health Effects of Overweight and Obesity in 195 Countries over 25 Years","volume":"377","author":"GBD 2015 Obesity Collaborators","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0333672.ref018","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/ckj\/sfab188","article-title":"The Latin American Dialysis and Renal Transplantation Registry: report 2019","volume":"15","author":"R Luxardo","year":"2021","journal-title":"Clinical Kidney J"},{"issue":"6","key":"pone.0333672.ref019","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1681\/ASN.2006121388","article-title":"Survival among patients with kidney failure in Jalisco, Mexico","volume":"18","author":"G Garcia-Garcia","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"pone.0333672.ref020","unstructured":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Available from: https:\/\/consensus.app\/papers\/inflammation-link-obesity-syndrome-type-diabetes-esser\/32e85379a83b5b3dbdc65e8e43c9b94f\/?utm_source=chatgpt. Accessed 2024 November 30."},{"issue":"2","key":"pone.0333672.ref021","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.dsx.2019.01.041","article-title":"How the association between obesity and inflammation may lead to insulin resistance and cancer","volume":"13","author":"MN Amin","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"pone.0333672.ref022","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000093632","article-title":"Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications","volume":"26","author":"PA Sarafidis","year":"2006","journal-title":"Am J Nephrol"},{"issue":"7121","key":"pone.0333672.ref023","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"SE Kahn","year":"2006","journal-title":"Nature"},{"issue":"2","key":"pone.0333672.ref024","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"N Esser","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"pone.0333672.ref025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fendo.2013.00052","article-title":"Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies","volume":"4","author":"MA McArdle","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"pone.0333672.ref026","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3181\/0705-MR-134","article-title":"Diabetic nephropathy: mechanisms of renal disease progression","volume":"233","author":"YS Kanwar","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"pone.0333672.ref027","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes","volume":"391","author":"V Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"pone.0333672.ref028","article-title":"Impacts of donor transitions on health systems in middle-income countries: a scoping review","year":"2022","journal-title":"Health Policy and Planning"},{"issue":"1","key":"pone.0333672.ref029","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1186\/s12889-021-11014-1","article-title":"Socioeconomic inequalities in lifestyle risk factors across low- and middle-income countries","volume":"21","author":"C Dieteren","year":"2021","journal-title":"BMC Public Health"},{"key":"pone.0333672.ref030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.genm.2009.02.002","article-title":"Gender differences in insulin resistance, body composition, and energy balance","author":"EB Geer","year":"2009","journal-title":"Gend Med"},{"issue":"3","key":"pone.0333672.ref031","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus","volume":"37","author":"A Kautzky-Willer","year":"2016","journal-title":"Endocr Rev"},{"key":"pone.0333672.ref032","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12875-016-0440-0","article-title":"The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study","volume":"17","author":"AE Thompson","year":"2016","journal-title":"BMC Fam Pract"},{"issue":"13","key":"pone.0333672.ref033","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.3390\/ijms25137342","article-title":"Sex- and Gender-Related Differences in Obesity: From Pathophysiological Mechanisms to Clinical Implications","volume":"25","author":"A Koceva","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0333672.ref034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12966-017-0617-5","article-title":"How to get a nation walking: reach, retention, participant characteristics and program implications of Heart Foundation Walking, a nationwide Australian community-based walking program","volume":"14","author":"K Ball","year":"2017","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"8","key":"pone.0333672.ref035","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3945\/jn.117.251892","article-title":"After Mexico Implemented a Tax, Purchases of Sugar-Sweetened Beverages Decreased and Water Increased: Difference by Place of Residence, Household Composition, and Income Level","volume":"147","author":"MA Colchero","year":"2017","journal-title":"J Nutr"},{"key":"pone.0333672.ref036","article-title":"Estimated health impact, cost, and cost-effectiveness of taxation on unhealthy packaged foods in the Philippines: a modelling study","author":"A Saxena","year":"2025","journal-title":"Lancet Public Health"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:31:03Z","timestamp":1760117463000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333672"}},"subtitle":[],"editor":[{"given":"Claudio Alberto","family":"D\u00e1vila-Cervantes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0333672","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]}}}